338 related articles for article (PubMed ID: 12971795)
21. Role of drug metabolism for breaking tolerance and the localization of drug hypersensitivity.
Uetrecht J
Toxicology; 2005 Apr; 209(2):113-8. PubMed ID: 15767022
[TBL] [Abstract][Full Text] [Related]
22. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
23. Macrophages are involved in hexachlorobenzene-induced adverse immune effects.
Ezendam J; Kosterman K; Spijkerboer H; Bleumink R; Hassing I; van Rooijen N; Vos JG; Pieters R
Toxicol Appl Pharmacol; 2005 Nov; 209(1):19-27. PubMed ID: 16271622
[TBL] [Abstract][Full Text] [Related]
24. A role for alphabeta T cells in the resistant phase of the Brown Norway rat model of vasculitis.
Vinen CS; Turner DR; Oliveira DB
Clin Exp Immunol; 2005 Apr; 140(1):32-40. PubMed ID: 15762872
[TBL] [Abstract][Full Text] [Related]
25. Case-control exploration of relationships between early rash or liver toxicity and plasma concentrations of nevirapine and primary metabolites.
Hall DB; Macgregor TR
HIV Clin Trials; 2007; 8(6):391-9. PubMed ID: 18042504
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide association study identifies variations in 6p21.3 associated with nevirapine-induced rash.
Chantarangsu S; Mushiroda T; Mahasirimongkol S; Kiertiburanakul S; Sungkanuparph S; Manosuthi W; Tantisiriwat W; Charoenyingwattana A; Sura T; Takahashi A; Kubo M; Kamatani N; Chantratita W; Nakamura Y
Clin Infect Dis; 2011 Aug; 53(4):341-8. PubMed ID: 21810746
[TBL] [Abstract][Full Text] [Related]
27. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
Smith KJ; Skelton HG; Yeager J; Ledsky R; Ng TH; Wagner KF
Clin Exp Dermatol; 1997 May; 22(3):118-23. PubMed ID: 9425690
[TBL] [Abstract][Full Text] [Related]
28. Oral adverse effects due to the use of Nevirapine.
Moura MD; Senna MI; Madureira DF; Fonseca LM; Mesquita RA
J Contemp Dent Pract; 2008 Jan; 9(1):84-90. PubMed ID: 18176653
[TBL] [Abstract][Full Text] [Related]
29. Livedoid skin reaction probably due to imatinib therapy.
Martínez-González MC; del Pozo J; Yebra-Pimentel MT; Pérez M; Almagro M; Fonseca E
Ann Pharmacother; 2007 Jan; 41(1):148-52. PubMed ID: 17190842
[TBL] [Abstract][Full Text] [Related]
30. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
[TBL] [Abstract][Full Text] [Related]
32. General 4-week toxicity study with EMS in the rat.
Pfister T; Eichinger-Chapelon A
Toxicol Lett; 2009 Nov; 190(3):271-85. PubMed ID: 19442710
[TBL] [Abstract][Full Text] [Related]
33. Identification of danger signals in nevirapine-induced skin rash.
Zhang X; Sharma AM; Uetrecht J
Chem Res Toxicol; 2013 Sep; 26(9):1378-83. PubMed ID: 23947594
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic intrabone marrow-bone marrow transplantation plus donor lymphocyte infusion suppresses growth of colon cancer cells implanted in skin and liver of rats.
Koike Y; Adachi Y; Suzuki Y; Iwasaki M; Koike-Kiriyama N; Minamino K; Nakano K; Mukaide H; Shigematsu A; Kiyozuka Y; Tubura A; Kamiyama Y; Ikehara S
Stem Cells; 2007 Feb; 25(2):385-91. PubMed ID: 17284650
[TBL] [Abstract][Full Text] [Related]
35. Nevirapine-associated rash in a Jamaican child with HIV/AIDS.
Steel-Duncan JC; Pierre R; Gabay L; Christie CD
West Indian Med J; 2004 Oct; 53(5):356-8. PubMed ID: 15675504
[TBL] [Abstract][Full Text] [Related]
36. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test.
Padial A; Antunez C; Blanca-Lopez N; Fernandez TD; Cornejo-Garcia JA; Mayorga C; Torres MJ; Blanca M
Clin Exp Allergy; 2008 May; 38(5):822-8. PubMed ID: 18331363
[TBL] [Abstract][Full Text] [Related]
37. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
Santos RP; Ramilo O; Barton T
Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815
[TBL] [Abstract][Full Text] [Related]
38. Third-trimester maternal toxicity with nevirapine use in pregnancy.
Joy S; Poi M; Hughes L; Brady MT; Koletar SL; Para MF; Fan-Havard P
Obstet Gynecol; 2005 Nov; 106(5 Pt 1):1032-8. PubMed ID: 16260522
[TBL] [Abstract][Full Text] [Related]
39. Regional oral tolerance in transgenic 2C mice.
Margenthaler JA; Flye MW
Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
[TBL] [Abstract][Full Text] [Related]
40. Animal models of idiosyncratic drug reactions.
Ng W; Lobach AR; Zhu X; Chen X; Liu F; Metushi IG; Sharma A; Li J; Cai P; Ip J; Novalen M; Popovic M; Zhang X; Tanino T; Nakagawa T; Li Y; Uetrecht J
Adv Pharmacol; 2012; 63():81-135. PubMed ID: 22776640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
